NAV | $27.39 | Daily Change | $0.00 | 0.00% |
Market Price | $27.25 | Daily Change | -$0.04 | -0.15% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2021
Inception Date | 05/09/16 |
Total Expense Ratio | 0.50% |
Net Assets | $64.36 million |
NAV | $27.39 |
Fact Sheet |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Ticker | AGNG |
Bloomberg Index Ticker | ILNGRNT |
CUSIP | 37954Y772 |
ISIN | US37954Y7720 |
Primary Exchange | Nasdaq |
Shares Outstanding | 2,350,000 |
Number of Holdings | 97 |
30-Day Median Bid-Ask Spread | 0.27% |
30-Day SEC Yield | 0.86% |
Distribution Frequency | Semi-Annually |
NAV | $27.39 | Daily Change | $0.00 | 0.00% |
Market Price | $27.25 | Daily Change | -$0.04 | -0.15% |
As of recent (12/31/22)
As of recent (12/31/22)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | -8.52% | -8.64% | -8.36% |
3 Years | 4.18% | 4.14% | 4.39% |
5 Years | 7.01% | 6.89% | 7.22% |
Since Inception | 9.34% | 9.65% | 9.62% |
1 Year | 1.75% | 1.37% | 1.93% |
3 Years | 5.47% | 5.28% | 5.69% |
5 Years | 6.04% | 6.00% | 6.25% |
Since Inception | 9.65% | 9.96% | 9.93% |
Year-to-Date | -8.52% | -8.64% | -8.36% |
1 Month | -0.75% | -1.42% | -0.70% |
3 Months | 11.66% | 11.59% | 11.71% |
Since Inception | 81.07% | 84.53% | 84.12% |
Year-to-Date | 2.71% | 2.71% | 2.73% |
1 Month | 2.71% | 2.71% | 2.73% |
3 Months | 8.06% | 8.12% | 8.13% |
Since Inception | 85.97% | 89.53% | 89.16% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
3.87 | NOVOB DC | NOVO NORDISK A/S-B | BHC8X90 | 137.32 | 18,149 | 2,492,183.67 |
3.61 | LLY | ELI LILLY & CO | 2516152 | 339.08 | 6,856 | 2,324,732.48 |
3.61 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 783.13 | 2,964 | 2,321,197.32 |
3.56 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 48.50 | 47,196 | 2,289,006.00 |
3.44 | SYK | STRYKER CORP | 2853688 | 283.14 | 7,813 | 2,212,172.82 |
3.23 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 74.45 | 27,932 | 2,079,537.40 |
3.21 | AMGN | AMGEN INC | 2023607 | 245.17 | 8,430 | 2,066,783.10 |
3.15 | ALC SW | ALCON INC | BJT1GR5 | 76.35 | 26,591 | 2,030,098.13 |
3.01 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 63.44 | 30,483 | 1,933,841.52 |
2.95 | JNJ | JOHNSON & JOHNSON | 2475833 | 164.61 | 11,533 | 1,898,447.13 |
2.91 | BIIB | BIOGEN INC | 2455965 | 283.63 | 6,600 | 1,871,958.00 |
2.81 | ABBV | ABBVIE INC | B92SR70 | 145.20 | 12,453 | 1,808,175.60 |
2.78 | DXCM | DEXCOM INC | B0796X4 | 108.43 | 16,491 | 1,788,119.13 |
2.56 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 25.77 | 63,827 | 1,644,870.11 |
2.55 | WELL | WELLTOWER INC | BYVYHH4 | 75.82 | 21,653 | 1,641,730.46 |
2.55 | MDT | MEDTRONIC PLC | BTN1Y11 | 87.10 | 18,817 | 1,638,960.70 |
2.51 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 354.63 | 4,556 | 1,615,697.39 |
2.23 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 82.12 | 17,447 | 1,432,747.64 |
1.89 | ZBH | ZIMMER BIOMET HO | 2783815 | 129.45 | 9,410 | 1,218,124.50 |
1.85 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 256.90 | 4,627 | 1,188,676.30 |
1.85 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 14.42 | 82,394 | 1,188,060.62 |
1.79 | GMAB DC | GENMAB A/S | 4595739 | 388.11 | 2,973 | 1,153,843.23 |
1.76 | SGEN | SEAGEN INC | BLPK4D2 | 138.00 | 8,225 | 1,135,050.00 |
1.59 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 143.99 | 7,125 | 1,025,910.42 |
1.54 | 4543 JP | TERUMO CORP | 6885074 | 29.11 | 34,054 | 991,162.67 |
1.47 | VTR | VENTAS INC | 2927925 | 52.60 | 17,935 | 943,381.00 |
1.42 | PODD | INSULET CORP | B1XGNW4 | 295.19 | 3,094 | 913,317.86 |
1.37 | 068270 KS | CELLTRION INC | B0C5YV1 | 137.55 | 6,418 | 882,758.67 |
1.29 | INCY | INCYTE CORP | 2471950 | 83.61 | 9,927 | 829,996.47 |
1.18 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 267.71 | 2,834 | 758,682.06 |
1.11 | UCB BB | UCB SA | 5596991 | 81.54 | 8,731 | 711,926.02 |
0.88 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 14.38 | 39,294 | 565,169.10 |
0.86 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.09 | 263,443 | 550,035.86 |
0.85 | TFX | TELEFLEX INC | 2881407 | 258.47 | 2,111 | 545,630.17 |
0.81 | EXAS | EXACT SCIENCES CORP | 2719951 | 67.45 | 7,766 | 523,816.70 |
0.80 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 252.80 | 2,043 | 516,470.40 |
0.79 | FME GR | FRESENIUS MEDICA | 5129074 | 38.66 | 13,099 | 506,455.22 |
0.73 | NBIX | NEUROCRINE BIOSC | 2623911 | 110.03 | 4,266 | 469,387.98 |
0.72 | 1858 HK | BEIJING CHUNLI-H | BVVPXP6 | 2.73 | 170,266 | 465,527.86 |
0.72 | COH AU | COCHLEAR LTD | 6211798 | 154.83 | 2,990 | 462,935.99 |
0.69 | NVCR | NOVOCURE LTD | BYSS4X4 | 94.22 | 4,698 | 442,645.56 |
0.63 | FGEN | FIBROGEN INC | BSDRYR8 | 24.57 | 16,431 | 403,709.67 |
0.62 | AGL | AGILON HEALTH INC | BLR4TK4 | 22.05 | 18,061 | 398,245.05 |
0.58 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 1.15 | 326,989 | 375,116.44 |
0.57 | DVA | DAVITA INC | 2898087 | 85.48 | 4,298 | 367,393.04 |
0.54 | DEMANT DC | DEMANT A/S | BZ01RF1 | 31.91 | 10,804 | 344,777.50 |
0.50 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.56 | 579,824 | 324,452.52 |
0.50 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 52.65 | 6,137 | 323,113.05 |
0.48 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 3.36 | 91,802 | 308,335.27 |
0.48 | OHI | OMEGA HEALTHCARE | 2043274 | 28.72 | 10,719 | 307,849.68 |
0.48 | AMP IM | AMPLIFON SPA | B14NJ71 | 30.23 | 10,157 | 307,019.26 |
0.43 | MNKD | MANNKIND CORP | BF081J4 | 5.18 | 53,629 | 277,798.22 |
0.42 | SILK | SILK ROAD MEDICAL INC | BGHVXJ7 | 54.81 | 4,908 | 269,007.48 |
0.39 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.42 | 609,892 | 253,431.73 |
0.39 | EXEL | EXELIXIS INC | 2576941 | 17.55 | 14,357 | 251,965.35 |
0.37 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 73.33 | 3,241 | 237,662.53 |
0.36 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 2.13 | 109,940 | 234,025.21 |
0.36 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 92.40 | 2,513 | 232,201.20 |
0.36 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 10.65 | 21,632 | 230,380.80 |
0.35 | LHCG | LHC GROUP INC | B06DT50 | 158.65 | 1,415 | 224,489.75 |
0.34 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 13.48 | 16,394 | 220,991.12 |
0.34 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 59.17 | 3,731 | 220,763.27 |
0.34 | LTC | LTC PROPERTIES INC | 2498788 | 38.31 | 5,628 | 215,608.68 |
0.33 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 30.20 | 7,028 | 212,245.60 |
0.32 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 13.59 | 15,094 | 205,127.46 |
0.32 | SGHT | SIGHT SCIENCES INC | BN2T5Q6 | 11.54 | 17,668 | 203,888.72 |
0.31 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 73.50 | 2,749 | 202,051.50 |
0.31 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 7.47 | 27,029 | 201,883.95 |
0.31 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 31.70 | 6,310 | 200,027.00 |
0.31 | 4547 JP | KISSEI PHARM CO | 6494061 | 18.77 | 10,570 | 198,429.49 |
0.30 | 8086 JP | NIPRO CORP | 6641599 | 7.84 | 24,837 | 194,844.60 |
0.29 | NUVA | NUVASIVE INC | B00GJC2 | 48.12 | 3,869 | 186,176.28 |
0.29 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 61.91 | 2,968 | 183,748.88 |
0.28 | GKOS | GLAUKOS CORP | BYMWL19 | 51.52 | 3,493 | 179,959.36 |
0.27 | GN DC | GN STORE NORD A/S | 4501093 | 27.68 | 6,242 | 172,747.82 |
0.27 | PHM SM | PHARMA MAR SA | BMW2GT8 | 66.51 | 2,560 | 170,273.83 |
0.26 | INGN | INOGEN INC | BJSVLL5 | 26.00 | 6,378 | 165,828.00 |
0.24 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 9.16 | 16,563 | 151,648.37 |
0.23 | ACAD | ACADIA PHARMACEU | 2713317 | 19.83 | 7,586 | 150,430.38 |
0.23 | LIVN | LIVANOVA PLC | BYMT0J1 | 58.14 | 2,568 | 149,303.52 |
0.23 | AED BB | AEDIFICA | B1G5XP1 | 90.82 | 1,618 | 146,951.97 |
0.23 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 7.34 | 20,022 | 146,924.35 |
0.22 | PNTG | PENNANT GROUP INC/THE | BKTC976 | 12.76 | 11,293 | 144,098.68 |
0.22 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 4.27 | 32,852 | 140,362.72 |
0.22 | ALEC | ALECTOR INC | BJ4LDC4 | 9.49 | 14,683 | 139,341.67 |
0.21 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 45.65 | 2,986 | 136,310.90 |
0.21 | AMED | AMEDISYS INC | 2024332 | 92.14 | 1,448 | 133,418.72 |
0.20 | ANGO | ANGIODYNAMICS INC | B00CR04 | 13.43 | 9,595 | 128,860.85 |
0.19 | CMAX | CAREMAX INC | BMD9BG0 | 4.53 | 27,119 | 122,849.07 |
0.16 | AMRN | AMARIN CORP PLC -ADR | 2301938 | 1.89 | 55,853 | 105,562.17 |
0.15 | HRTX | HERON THERAPEUTICS INC | BJ0XLZ3 | 2.84 | 32,757 | 93,029.88 |
0.14 | KORI FP | KORIAN | B1HKRM0 | 9.78 | 9,506 | 92,993.70 |
0.13 | BKD | BROOKDALE SR | B0PZN33 | 2.80 | 30,346 | 84,968.80 |
0.13 | CASH | 1.00 | 81,880 | 81,879.88 | ||
0.09 | CANO | CANO HEALTH INC | BN0WWW2 | 1.49 | 36,847 | 54,902.03 |
0.08 | DHC | DIVERSIFIED HEAL | BKRN595 | 0.75 | 71,357 | 53,160.97 |
0.03 | ORP FP | ORPEA | 7339451 | 3.02 | 5,277 | 15,916.60 |
0.00 | EURO | 1.09 | 1 | 1.39 | ||
0.00 | BRITISH STERLING POUND | 1.17 | 0 | 0.07 | ||
0.00 | DANISH KRONE | 0.00 | 0 | 0.00 | ||
0.00 | HONG KONG DOLLAR | 0.00 | 0 | 0.00 | ||
0.00 | KOREAN WON | 0.00 | 0 | 0.00 | ||
0.00 | SWEDISH KRONE | 0.00 | 0 | 0.00 | ||
0.00 | RADIUS HEALTH INC - CVR | 2KFF9T0 | 0.00 | 19,104 | 0.00 | |
0.00 | JAPANESE YEN | 0.01 | -2 | -0.02 | ||
0.00 | SWISS FRANC | 1.00 | 0 | -0.03 | ||
0.00 | AUSTRALIAN DOLLAR | 0.69 | 0 | -0.09 | ||
0.00 | CANADIAN DOLLAR | 0.74 | 0 | -0.28 |
Sector | Weight (%) | |
---|---|---|
Health Care | 94.7 | |
Real Estate | 5.3 |
Source: AltaVista Research, LLC
Country | Weight (%) | |
---|---|---|
United States | 59.2 | |
Switzerland | 8.2 | |
Japan | 6.9 | |
Denmark | 6.7 | |
China | 5.2 | |
Britain | 5.0 | |
Ireland | 2.5 | |
South Korea | 1.3 | |
Belgium | 1.3 | |
Germany | 0.7 | |
Australia | 0.7 | |
Other/Cash | 2.3 |
Source: AltaVista Research, LLC
Return on Equity | 13.10% | |
Weighted Avg. Market Cap | 61,168 M | |
2022 | 2023 | |
Price-to-earnings | 28.31 | 25.15 |
Price-to-book value | 3.42 | 3.18 |
Source: AltaVista Research, LLC
Versus | Beta |
---|---|
S&P 500 | 0.71 |
MSCI EAFE | 0.71 |
MSCI Emg. Mkts | 0.56 |
Standard Deviation | 18.60% |
Source: AltaVista Research, LLC
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.